BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16212965)

  • 1. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.
    Gómez-Hernández A; Martín-Ventura JL; Sánchez-Galán E; Vidal C; Ortego M; Blanco-Colio LM; Ortega L; Tuñón J; Egido J
    Atherosclerosis; 2006 Jul; 187(1):139-49. PubMed ID: 16212965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.
    Gómez-Hernández A; Sánchez-Galán E; Martín-Ventura JL; Vidal C; Blanco-Colio LM; Ortego M; Vega M; Serrano J; Ortega L; Hernández G; Tunón J; Egido J
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):60-9. PubMed ID: 16424787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
    Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
    Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans.
    Cipollone F; Fazia M; Iezzi A; Ciabattoni G; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; De Luca M; Prontera C; Chiarelli F; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1259-65. PubMed ID: 15155382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
    Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages.
    Díaz-Muñoz MD; Osma-García IC; Cacheiro-Llaguno C; Fresno M; Iñiguez MA
    Cell Signal; 2010 Oct; 22(10):1427-36. PubMed ID: 20546888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
    Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
    Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COX-2 and mPGES-1 expression in carotid atherosclerotic plaques].
    Liu HF; Li XH; Yang QD; Miao W; Qi SS; Song XM; He GS; Dong HL; Zhang FQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):453-6. PubMed ID: 17680542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.
    Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Gómez-Hernández A; Arribas A; Ortega L; Tuñón J; Egido J
    Stroke; 2004 Feb; 35(2):458-63. PubMed ID: 14739407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.
    Båge T; Lindberg J; Lundeberg J; Modéer T; Yucel-Lindberg T
    BMC Genomics; 2010 Apr; 11():241. PubMed ID: 20398340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
    Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren AK; Klareskog L; Jakobsson PJ
    Arthritis Rheum; 2005 Nov; 52(11):3439-47. PubMed ID: 16255020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes.
    Nah SS; Choi IY; Lee CK; Oh JS; Kim YG; Moon HB; Yoo B
    Rheumatology (Oxford); 2008 Apr; 47(4):425-31. PubMed ID: 18285354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Areca nut extracts increased the expression of cyclooxygenase-2, prostaglandin E2 and interleukin-1α in human immune cells via oxidative stress.
    Chang LY; Wan HC; Lai YL; Chou IC; Chen YT; Hung SL
    Arch Oral Biol; 2013 Oct; 58(10):1523-31. PubMed ID: 23916228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
    Cipollone F; Fazia M; Iezzi A; Zucchelli M; Pini B; De Cesare D; Ucchino S; Spigonardo F; Bajocchi G; Bei R; Muraro R; Artese L; Piattelli A; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2003 Mar; 107(11):1479-85. PubMed ID: 12654603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
    Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
    Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells.
    Xue J; Hua YN; Xie ML; Gu ZL
    Biomed Pharmacother; 2010 Feb; 64(2):118-23. PubMed ID: 19880272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
    Cipollone F; Prontera C; Pini B; Marini M; Fazia M; De Cesare D; Iezzi A; Ucchino S; Boccoli G; Saba V; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2001 Aug; 104(8):921-7. PubMed ID: 11514380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of prostaglandin E2 synthases and E-prostanoid receptors in the spinal cord in a rat model of neuropathic pain.
    Kanda H; Kobayashi K; Yamanaka H; Okubo M; Dai Y; Noguchi K
    Brain Res; 2021 Jan; 1750():147153. PubMed ID: 33049240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.